These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 1406377

  • 1. Comparison of immunological effects of cholera toxin on autoimmune MRL/lpr and BXSB mice.
    Zhou NN, Nakai S, Oka M, Nagasawa H, Himeno K.
    Microbiol Immunol; 1992; 36(7):745-56. PubMed ID: 1406377
    [Abstract] [Full Text] [Related]

  • 2. Treatment of autoimmune MRL/Mp-lpr/lpr mice with cholera toxin.
    Fan JL, Himeno K, Tsuru S, Nomoto K.
    Clin Exp Immunol; 1987 Oct; 70(1):94-101. PubMed ID: 3500817
    [Abstract] [Full Text] [Related]

  • 3. Immunomodulating effect of a traditional Japanese medicine, hachimi-jio-gan (ba-wei-di-huang-wan), on Th1 predominance in autoimmune MRL/MP-lpr/lpr mice.
    Furuya Y, Kawakita T, Nomoto K.
    Int Immunopharmacol; 2001 Mar; 1(3):551-9. PubMed ID: 11367538
    [Abstract] [Full Text] [Related]

  • 4. Combined treatment of autoimmune MRL/Mp-lpr/lpr mice with cholera toxin plus irradiation. Combined treatment of autoimmune MRL/l mice.
    Fan JL, Himeno K, Hussain A, Nomoto K.
    Biotherapy; 1989 Mar; 1(2):97-102. PubMed ID: 2641464
    [Abstract] [Full Text] [Related]

  • 5. Effect of cyclophosphamide on lymphokine production in MRL/lpr.Yaa mice.
    Kamada H, Takaoka Y, Kitagaki K, Nagai H.
    Inflamm Res; 1995 Nov; 44(11):491-8. PubMed ID: 8597884
    [Abstract] [Full Text] [Related]

  • 6. Treatment effect of a traditional Chinese medicine, ren-shen-yang-rong-tang (Japanese name: ninjin-youei-to), on autoimmune MRL/MP-lpr/lpr mice.
    Nakai S, Kawakita T, Zhou NN, Matsuura K, Oka M, Nagasawa H, Saito Y, Suzuki A, Himeno K, Nomoto K.
    Int J Immunopharmacol; 1993 Jul; 15(5):589-96. PubMed ID: 8375941
    [Abstract] [Full Text] [Related]

  • 7. Studies on the mechanisms of the development of lupus nephritis in BXSB mice. II. Comparative studies between male BXSB and MRL/lpr mice at the onset period.
    Makino M, Fujiwara M, Watanabe H.
    J Clin Lab Immunol; 1988 Feb; 25(2):83-8. PubMed ID: 3259631
    [Abstract] [Full Text] [Related]

  • 8. Tamoxifen alleviates disease severity and decreases double negative T cells in autoimmune MRL-lpr/lpr mice.
    Wu WM, Suen JL, Lin BF, Chiang BL.
    Immunology; 2000 May; 100(1):110-8. PubMed ID: 10809966
    [Abstract] [Full Text] [Related]

  • 9. Combined treatment of autoimmune MRL/MP-lpr/lpr mice with a herbal medicine, Ren-shen-yang-rong-tang (Japanese name: Ninjin-youei-to) plus suboptimal dosage of prednisolone.
    Zhou NN, Nakai S, Kawakita T, Oka M, Nagasawa H, Himeno K, Nomoto K.
    Int J Immunopharmacol; 1994 Oct; 16(10):845-54. PubMed ID: 7843856
    [Abstract] [Full Text] [Related]

  • 10. Differential effect of the autoimmune Yaa and lpr genes on the acceleration of lupus-like syndrome in MRL/MpJ mice.
    Merino R, Shibata T, De Kossodo S, Izui S.
    Eur J Immunol; 1989 Nov; 19(11):2131-7. PubMed ID: 2599002
    [Abstract] [Full Text] [Related]

  • 11. IL-12 deficiency in MRL-Fas(lpr) mice delays nephritis and intrarenal IFN-gamma expression, and diminishes systemic pathology.
    Kikawada E, Lenda DM, Kelley VR.
    J Immunol; 2003 Apr 01; 170(7):3915-25. PubMed ID: 12646661
    [Abstract] [Full Text] [Related]

  • 12. Role of the costimulatory molecule CD28 in the development of lupus in MRL/lpr mice.
    Tada Y, Nagasawa K, Ho A, Morito F, Koarada S, Ushiyama O, Suzuki N, Ohta A, Mak TW.
    J Immunol; 1999 Sep 15; 163(6):3153-9. PubMed ID: 10477582
    [Abstract] [Full Text] [Related]

  • 13. Thymic microenvironmental abnormalities in MRL/MP-lpr/lpr, BXSB/MpJ Yaa and C3H HeJ-gld/gld mice.
    Takeoka Y, Yoshida SH, Van de Water J, Boyd R, Suehiro S, Ansari AA, Gershwin ME.
    J Autoimmun; 1995 Apr 15; 8(2):145-61. PubMed ID: 7612145
    [Abstract] [Full Text] [Related]

  • 14. Treatment of autoimmune MRL/lpr mice with anti-B220 monoclonal antibody reduces the level of anti-DNA antibodies and lymphadenopathies.
    Asensi V, Kimeno K, Kawamura I, Sakumoto M, Nomoto K.
    Immunology; 1989 Oct 15; 68(2):204-8. PubMed ID: 2478453
    [Abstract] [Full Text] [Related]

  • 15. Treatment of MRL/lpr mice, a genetic autoimmune model, with the Ras inhibitor, farnesylthiosalicylate (FTS).
    Katzav A, Kloog Y, Korczyn AD, Niv H, Karussis DM, Wang N, Rabinowitz R, Blank M, Shoenfeld Y, Chapman J.
    Clin Exp Immunol; 2001 Dec 15; 126(3):570-7. PubMed ID: 11737078
    [Abstract] [Full Text] [Related]

  • 16. Long-term treatment with 5,5-diphenylhydantoin reduces lymphadenopathy and anti-ssDNA autoantibodies in C57BL/6-lpr/lpr mice.
    Bloksma N, de Bakker JM, van Rooijen HJ, Punt P, Seinen W, Kammüller ME.
    Int J Immunopharmacol; 1994 Mar 15; 16(3):261-8. PubMed ID: 8206693
    [Abstract] [Full Text] [Related]

  • 17. Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice.
    Takahashi S, Fossati L, Iwamoto M, Merino R, Motta R, Kobayakawa T, Izui S.
    J Clin Invest; 1996 Apr 01; 97(7):1597-604. PubMed ID: 8601623
    [Abstract] [Full Text] [Related]

  • 18. In vitro and in vivo effects of pentoxifylline on macrophages and lymphocytes derived from autoimmune MRL-lpr/lpr mice.
    Hecht M, Müller M, Lohmann-Matthes ML, Emmendörffer A.
    J Leukoc Biol; 1995 Feb 01; 57(2):242-9. PubMed ID: 7852838
    [Abstract] [Full Text] [Related]

  • 19. Transplantation of human bone marrow mesenchymal stem cell ameliorates the autoimmune pathogenesis in MRL/lpr mice.
    Zhou K, Zhang H, Jin O, Feng X, Yao G, Hou Y, Sun L.
    Cell Mol Immunol; 2008 Dec 01; 5(6):417-24. PubMed ID: 19118507
    [Abstract] [Full Text] [Related]

  • 20. IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice.
    Schwarting A, Wada T, Kinoshita K, Tesch G, Kelley VR.
    J Immunol; 1998 Jul 01; 161(1):494-503. PubMed ID: 9647261
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.